This is to inform you that the US FDA concluded a pre-approval inspection for Site 3 Biocon Limited located at Hyderabad Telangana on 19 May 2023 with no observations.The above information will also be available on the website of the Company at www.biocon.com.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
